LY-2452473 Completed Phase 1 Trials for Healthy Subjects (HS)

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT01275157Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human Subjects